Follow
Rafał Jakub Bułdak
Rafał Jakub Bułdak
Department of Clinical Biochemistry and Laboratory Diagnostics, Collegium Medicum, University of
Verified email at uni.opole.pl
Title
Cited by
Cited by
Year
Potential role of leptin, adiponectin and three novel adipokines—visfatin, chemerin and vaspin—in chronic hepatitis
M Kukla, W Mazur, RJ Bułdak, K Żwirska-Korczala
Molecular medicine 17, 1397-1410, 2011
1452011
Metformin affects macrophages’ phenotype and improves the activity of glutathione peroxidase, superoxide dismutase, catalase and decreases malondialdehyde concentration in a …
Ł Bułdak, K Łabuzek, RJ Bułdak, M Kozłowski, G Machnik, S Liber, ...
Pharmacological Reports 66 (3), 418-429, 2014
1152014
Visfatin affects redox adaptative responses and proliferation in Me45 human malignant melanoma cells: an in vitro study
RJ Bułdak, Ł Bułdak, R Polaniak, M Kukla, E Birkner, R Kubina, ...
Oncology reports 29 (2), 771-778, 2013
104*2013
Short‐term exposure to 50 Hz ELF‐EMF alters the cisplatin‐induced oxidative response in AT478 murine squamous cell carcinoma cells
RJ Bułdak, R Polaniak, Ł Bułdak, K Żwirska‐Korczala, M Skonieczna, ...
Bioelectromagnetics 33 (8), 641-651, 2012
852012
The impact of coffee and its selected bioactive compounds on the development and progression of colorectal cancer in vivo and in vitro
RJ Bułdak, T Hejmo, M Osowski, Ł Bułdak, M Kukla, R Polaniak, E Birkner
Molecules 23 (12), 3309, 2018
792018
The ethanol extract of polish propolis exhibits anti-proliferative and/or pro-apoptotic effect on HCT 116 colon cancer and Me45 Malignant melanoma cells in vitro conditions
R Kubina, A Kabała-Dzik, A Dziedzic, B Bielec, RD Wojtyczka, RJ Bułdak, ...
Advances in clinical and experimental medicine 24 (2), 203-212, 2015
772015
Silver nanoparticles exhibit the dose-dependent anti-proliferative effect against human squamous carcinoma cells attenuated in the presence of berberine
A Dziedzic, R Kubina, RJ Bułdak, M Skonieczna, K Cholewa
Molecules 21 (3), 365, 2016
702016
Postprandial response of ghrelin and PYY and indices of low-grade chronic inflammation in lean young women with polycystic ovary syndrome
K Zwirska-Korczala, K Sodowski, SJ Konturek, D Kuka, M Kukla, ...
J Physiol Pharmacol 59 (Suppl 2), 161-178, 2008
602008
Anti-androgen hormonal therapy for cancer and other diseases
S Student, T Hejmo, A Poterała-Hejmo, A Leśniak, R Bułdak
European journal of pharmacology 866, 172783, 2020
572020
Exenatide (a GLP-1 agonist) expresses anti-inflammatory properties in cultured human monocytes/macrophages in a protein kinase A and B/Akt manner
Ł Bułdak, G Machnik, RJ Bułdak, K Łabuzek, A Bołdys, D Belowski, ...
Pharmacological Reports 68 (2), 329-337, 2016
542016
Significance of selected antioxidant enzymes in cancer cell progression
RJ Bułdak, Ł Bułdak, M Kukla, A Gabriel, K Żwirska-Korczala
Polish journal of pathology 65 (3), 167-175, 2014
472014
Circulating levels of omentin, leptin, VEGF, and HGF and their clinical relevance with PSA marker in prostate cancer
M Fryczkowski, RJ Bułdak, T Hejmo, M Kukla, K Żwirska-Korczala
Disease markers 2018, 2018
412018
Caffeic acid reduces the viability and migration rate of oral carcinoma cells (SCC-25) exposed to low concentrations of ethanol
A Dziedzic, R Kubina, A Kabała-Dzik, RD Wojtyczka, T Morawiec, ...
International Journal of Molecular Sciences 15 (10), 18725-18741, 2014
392014
Exenatide (a GLP-1 agonist) improves the antioxidative potential of in vitro cultured human monocytes/macrophages
Ł Bułdak, K Łabuzek, RJ Bułdak, G Machnik, A Bołdys, B Okopień
Naunyn-schmiedeberg's Archives of Pharmacology 388, 905-919, 2015
322015
Exogenous administration of visfatin affects cytokine secretion and increases oxidative stress in human malignant melanoma Me45 cells
RJ Buldak, R Polaniak, L Buldak, L Mielanczyk, M Kukla, M Skonieczna, ...
J Physiol Pharmacol 64 (3), 377-85, 2013
292013
Hepatic chemerin mRNA in morbidly obese patients with nonalcoholic fatty liver disease
M Kajor, M Kukla, M Waluga, Ł Liszka, M Dyaczyński, G Kowalski, ...
Polish Journal of Pathology 68 (2), 117-127, 2017
272017
Association between hepatic angiogenesis and serum adipokine profile in non-obese chronic hepatitis C patients
M Kukla, A Berdowska, A Gabriel, T Sawczyn, W Mazur, ...
Polish Journal of Pathology 62 (4), 218-228, 2011
272011
Viability and oxidative response of human colorectal HCT-116 cancer cells treated with visfatin/eNampt in vitro
RJ Buldak, M Gowarzewski, L Buldak, M Skonieczna, M Kukla, ...
J Physiol Pharmacol 66 (4), 557-66, 2015
262015
Serum FGF21 and RBP4 levels in patients with chronic hepatitis C
M Kukla, A Berdowska, D Stygar, A Gabriel, W Mazur, B Łogiewa-Bazger, ...
Scandinavian journal of gastroenterology 47 (8-9), 1037-1047, 2012
262012
Exenatide and metformin express their anti-inflammatory effects on human monocytes/macrophages by the attenuation of MAPKs and NFκB signaling
Ł Bułdak, G Machnik, RJ Bułdak, K Łabuzek, A Bołdys, B Okopień
Naunyn-Schmiedeberg's archives of pharmacology 389, 1103-1115, 2016
252016
The system can't perform the operation now. Try again later.
Articles 1–20